What is Johnson & Johnson's xarelto — percent change (as a percent)?

Johnson & Johnson (JNJ) reported xarelto — percent change (as a percent) of 14.8% in Q3 2025.

How has Johnson & Johnson's xarelto — percent change (as a percent) changed year-over-year?

Johnson & Johnson's xarelto — percent change (as a percent) increased by 242.3% year-over-year, from -10.4% to 14.8%.

What does xarelto — percent change (as a percent) mean?

The percentage growth or decline in revenue for a specific product compared to a prior period.

Xarelto — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson Xarelto — Percent Change (as a percent) increased by 32.1% to 14.8% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 242.3%, from -10.4% to 14.8%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ3 2025

How to read this metric

A positive percentage indicates growth and market share expansion, whereas a negative percentage suggests market saturation, loss of exclusivity, or competitive displacement.

Detailed definition

This metric measures the period-over-period growth rate of revenue for a specific pharmaceutical product line. It provid...

Peer comparison

Comparable to year-over-year or sequential growth rate metrics reported for key therapeutic assets by peer pharmaceutical firms.

Metric ID: jnj_segment_xarelto_percent_change_as_a_percent

Historical Data

16 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25
Value	23.4%	3.6%	1.6%	4.6%	-27.6%	14.2%	16.8%	27.4%	-18.8%	-20.8%	-15.8%	-10.4%	47.6%	66.6%	11.2%	14.8%
QoQ Change	—	-84.6%	-55.6%	+187.5%	-700.0%	+151.4%	+18.3%	+63.1%	-168.6%	-10.6%	+24.0%	+34.2%	+557.7%	+39.9%	-83.2%	+32.1%
YoY Change	—	—	—	—	-217.9%	+294.4%	+950.0%	+199.3%	-232.4%	—	-157.7%	+44.7%	—	+420.2%	+170.9%	+242.3%

Range-27.6% – 66.6%

CAGR-11.5%

Avg YoY Growth+171.4%

Median YoY Growth+185.1%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's xarelto — percent change (as a percent)?: Johnson & Johnson (JNJ) reported xarelto — percent change (as a percent) of 14.8% in Q3 2025.
How has Johnson & Johnson's xarelto — percent change (as a percent) changed year-over-year?: Johnson & Johnson's xarelto — percent change (as a percent) increased by 242.3% year-over-year, from -10.4% to 14.8%.
What does xarelto — percent change (as a percent) mean?: The percentage growth or decline in revenue for a specific product compared to a prior period.